| scholarly article | Q13442814 |
| P50 | author | Rod T Mitchell | Q38642118 |
| P2093 | author name string | Norah Spears | |
| Federica Lopes | |||
| Sophie Nash | |||
| Rowena Smith | |||
| P2860 | cites work | How do chemotherapeutic agents damage the ovary? | Q28267696 |
| Impact of cancer therapies on ovarian reserve | Q28384958 | ||
| Phase 1 evaluation of EZN-2208, a polyethylene glycol conjugate of SN38, in children adolescents and young adults with relapsed or refractory solid tumors | Q33416097 | ||
| Prepubertal human spermatogonia and mouse gonocytes share conserved gene expression of germline stem cell regulatory molecules | Q33564776 | ||
| Fertility preservation for cancer patients: a review | Q33771927 | ||
| Spermatogonial stem cells in higher primates: are there differences from those in rodents? | Q33956993 | ||
| In vitro production of functional sperm in cultured neonatal mouse testes | Q34172831 | ||
| Oncofertility and preservation of reproductive capacity in children and young adults | Q34180625 | ||
| Docetaxel induces moderate ovarian toxicity in mice, primarily affecting granulosa cells of early growing follicles | Q34230276 | ||
| Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. | Q34380985 | ||
| The impact of chemotherapy on male fertility: a survey of the biologic basis and clinical aspects | Q34460125 | ||
| Cisplatin and doxorubicin induce distinct mechanisms of ovarian follicle loss; imatinib provides selective protection only against cisplatin | Q34905992 | ||
| Phase I dose escalation and pharmacokinetic study of oral gefitinib and irinotecan in children with refractory solid tumors | Q36036684 | ||
| Understanding Fertility in Young Female Cancer Patients | Q36218039 | ||
| Relationship between spermatogonial stem cell survival and testis function after cytotoxic therapy | Q36291386 | ||
| Pregnancy after chemotherapy in male and female survivors of childhood cancer treated between 1970 and 1999: a report from the Childhood Cancer Survivor Study cohort. | Q37004233 | ||
| Effects of chemotherapy and radiotherapy on spermatogenesis in humans | Q37305907 | ||
| Male fertility and strategies for fertility preservation following childhood cancer treatment. | Q37417040 | ||
| Fertility preservation medicine: a new field in the care of young cancer survivors | Q37419257 | ||
| Fertility preservation in girls and young women | Q37875896 | ||
| What lies behind chemotherapy-induced ovarian toxicity? | Q38015240 | ||
| Infertility in reproductive-age female cancer survivors. | Q38343285 | ||
| Cancer treatment and gonadal function: experimental and established strategies for fertility preservation in children and young adults. | Q38420984 | ||
| A European perspective on testicular tissue cryopreservation for fertility preservation in prepubertal and adolescent boys | Q38584517 | ||
| Effect of childhood acute lymphoblastic leukemia therapy on spermatogonia populations and future fertility | Q39992776 | ||
| Development and characterization of a novel liposome-based formulation of SN-38. | Q40599002 | ||
| Reproduction post-chemotherapy in young cancer patients | Q40729855 | ||
| RNA-seq reveals determinants for irinotecan sensitivity/resistance in colorectal cancer cell lines | Q41138517 | ||
| Late morfofunctional alterations of the Sertoli cell caused by doxorubicin administered to prepubertal rats | Q41564520 | ||
| Male fertility in long-term survivors of childhood acute lymphoblastic leukaemia | Q41960781 | ||
| Testicular histology and function following long-term chemotherapy of acute leukemia in children and outcome of the patients who received testicular biopsy. | Q43883704 | ||
| Phase I study of irinotecan in pediatric patients with malignant solid tumors | Q43980094 | ||
| Clinical pharmacokinetics of irinotecan and its metabolites: a population analysis | Q44083716 | ||
| Long-term survival of human spermatogonial stem cells in mouse testes | Q44245848 | ||
| Impact of cyclophosphamide on long-term reduction in sperm count in men treated with combination chemotherapy for Ewing and soft tissue sarcomas | Q44943988 | ||
| Decreased serum inhibin B/FSH ratio as a marker of Sertoli cell function in male survivors after chemotherapy in childhood and adolescence | Q44990547 | ||
| A phase I study of irinotecan administered on a weekly schedule in pediatric patients | Q46379409 | ||
| Irinotecan HCl, an anticancer topoisomerase I inhibitor, frequently induces ovarian failure in premenopausal and perimenopausal women | Q46634287 | ||
| A novel molecular mechanism for anticancer drug-induced ovarian failure: Irinotecan HCl, an anticancer topoisomerase I inhibitor, induces specific FasL expression in granulosa cells of large ovarian follicles to enhance follicular apoptosis | Q46634345 | ||
| The radiation-induced block in spermatogonial differentiation is due to damage to the somatic environment, not the germ cells. | Q50704788 | ||
| Ovarian reserve after treatment with alkylating agents during childhood | Q61183133 | ||
| Intracellular roles of SN-38, a metabolite of the camptothecin derivative CPT-11, in the antitumor effect of CPT-11 | Q68248525 | ||
| Regulation of proliferation and differentiation in spermatogonial stem cells: the role of c-kit and its ligand SCF | Q73685417 | ||
| Topoisomerase-I inhibitor SN-38 can induce DNA damage and chromosomal aberrations independent from DNA synthesis | Q77703627 | ||
| Cortical fibrosis and blood-vessels damage in human ovaries exposed to chemotherapy. Potential mechanisms of ovarian injury | Q79836914 | ||
| Estimation of nuclear population from microtome sections | Q82126847 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 11 | |
| P921 | main subject | irinotecan | Q412197 |
| P304 | page(s) | 745-755 | |
| P577 | publication date | 2016-07-28 | |
| P1433 | published in | Molecular Human Reproduction | Q15761794 |
| P1476 | title | Irinotecan metabolite SN38 results in germ cell loss in the testis but not in the ovary of prepubertal mice | |
| P478 | volume | 22 |
| Q48147030 | Chemotherapy drugs cyclophosphamide, cisplatin and doxorubicin induce germ cell loss in an in vitro model of the prepubertal testis |
| Q92740894 | Comparative gonadotoxicity of the chemotherapy drugs cisplatin and carboplatin on prepubertal mouse gonads |
| Q89862409 | Exposure to Chemotherapy During Childhood or Adulthood and Consequences on Spermatogenesis and Male Fertility |
| Q58599829 | How does chemotherapy treatment damage the prepubertal testis? |
| Q100533819 | Poly (ADP-ribose) polymerase inhibitor exposure reduces ovarian reserve followed by dysfunction in granulosa cells |
| Q40494116 | Relationship between UGT1A1*6/*28 gene polymorphisms and the efficacy and toxicity of irinotecan-based chemotherapy |
| Q91842079 | Single and combined effects of cisplatin and doxorubicin on the human and mouse ovary in vitro |
Search more.